| Krishna Kumar Naga Venkata Jakka, RPH | |
|
615 Howard Ave, New Haven, CT 06519-2112 | |
| (904) 314-2276 | |
| (203) 549-0650 |
| Full Name | Krishna Kumar Naga Venkata Jakka |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 615 Howard Ave, New Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023355641 | NPI | - | NPPES |
| 28R03209900 | Other | NJ | PHARMACIST |
| 056726-1 | Other | NY | PHARMACIST |
| PCT.0010976 | Other | CT | PHARMACIST |
| PS41668 | Other | FL | PHARMACIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 056726-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Krishna Kumar Naga Venkata Jakka, RPH 1201 Woodlandhills Dr, Trumbull, CT 06611 Ph: (904) 314-2276 | Krishna Kumar Naga Venkata Jakka, RPH 615 Howard Ave, New Haven, CT 06519-2112 Ph: (904) 314-2276 |
News Archive
Bristol-Myers Squibb Company today announced first quarter results that included strong sales and earnings growth, and several key R&D milestones—most notably U.S. regulatory approval for YERVOY. The company also confirmed guidance for the year.
Rainfall and temperature affect the abundance of two mosquito species linked to West Nile Virus in storm catch basins in suburban Chicago, two University of Illinois researchers report.
A study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned, according to Ozonics International, LLC, a veteran-owned biotechnology company engaged in the research and development of ozone-based medical therapies.
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
Investigators at The Saban Research Institute of Children's Hospital Los Angeles have provided the first evidence that Eya1 protein phosphatase is a crucial regulator of the development of embryonic lung epithelial stem cells.
› Verified 2 days ago
Franklin Chen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-200-3100 | |
Heather Kutzler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Alexander Aliling, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Mrs. Martha Lee Asarisi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17 Hillhouse Ave, New Haven, CT 06511 Phone: 203-432-0033 | |
Dr. Amanda Lee Staak, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Ferry St, New Haven, CT 06513 Phone: 203-777-0695 | |
Charles William Jones Jr., PHARMD, BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, New Haven, CT 06511 Phone: 203-789-6267 | |
Barbara Cmuchowski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Park St, New Haven, CT 06519 Phone: 203-200-4444 |